The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders

Status Recruiting

Clinical Trial Summary

This study seeks to determine the biologic causes of inflammation in patients with Transverse Myelitis (TM) Neuromyelitis Optica Spectrum Disorder (NMOSD) and related conditions. While patients will be treated according to decisions with their treating physician, this study will collect data and samples from patients prospectively to gain a better understanding of the disease. We are seeking to understand why some patients respond to medications, while others do not. We also seek to understand what happens biologically, preceding relapses. Gathering these data and samples will allow researchers to identify new ways of diagnosing and treating these diseases. Data and samples will be shared with researchers around the world to support collaborative efforts to treat these conditions.

Clinical Trial Description

This study seeks to determine the biologic causes of inflammation in patients with Neuromyelitis Optica (NMO), Transverse Myelitis (TM), optic neuritis (ON), related conditions and healthy controls. While patients will be treated according to decisions with their treating physician, this study will collect data and samples from patients prospectively to gain a better understanding of the disease. We are seeking to understand why some patients respond to medications, while others do not. We also seek to understand what happens biologically, preceding relapses. Gathering these data and samples will allow researchers to identify new ways of diagnosing and treating these diseases. Data and samples will be shared with researchers around the world to support collaborative efforts to treat these conditions. Patients will agree to share medical records, complete questionnaires and donate samples on a timed basis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01623076
Study type	Observational
Source	University of Texas Southwestern Medical Center
Contact	Jan Cameron-Watts, RN
Phone	214-645-0555
Email	jan.cameronwatts@utsouthwestern.edu
Status	Recruiting
Phase
Start date	June 2012
Completion date	June 2025

View Details

See also
Status	Clinical Trial	Phase
Unknown status	`NCT00261326` - Simvastatin Treatment of Patients With Acute Optic Neuritis	Phase 3
Active, not recruiting	`NCT03963310` - Optical Coherence Tomography and Optic Neuritis Not Related to Multiple Sclerosis
Recruiting	`NCT03586557` - Effectiveness of Plasma Exchange in Treating With Severe Acute AQP4-Ab Positive Optic Neuritis	N/A
Recruiting	`NCT05487989` - VIsual Pathways Model in Neuro-inflammatory Disorders
Terminated	`NCT04131764` - Diagnosis of ON With or Without MS or NMOSD
Not yet recruiting	`NCT06453694` - Efgartigimod for the Treatment of Acute Optic Neuritis	Phase 2
Completed	`NCT01962571` - Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial	Phase 3
Recruiting	`NCT03302585` - High-Dose Vitamin D Induction in Optic Neuritis	Phase 2
Recruiting	`NCT02886377` - The Correlation Between AQP-4 Ab and the Visual Function of Patients With Demyelinating ON at Onset	N/A
Completed	`NCT01987167` - Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis	Early Phase 1
Completed	`NCT01451593` - Neuroprotection With Phenytoin in Optic Neuritis	Phase 2
Completed	`NCT03630497` - BN201 SAD MAD Study in Healthy Subjects	Phase 1
Completed	`NCT01337986` - Ampyra for Optic Neuritis in Multiple Sclerosis	Phase 2/Phase 3
Completed	`NCT01274702` - Visual Reconstitution Therapy After Optic Neuritis	Phase 2
Active, not recruiting	`NCT00445367` - Biobank For MS And Other Demyelinating Diseases
Withdrawn	`NCT00037115` - Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.	Phase 4
Not yet recruiting	`NCT06389968` - Light Stimulation to Improve Visual Function After Optic Neuritis in Persons With Multiple Sclerosis	N/A
Recruiting	`NCT04257734` - Epidemiologic and Clinical Characteristics of Optic Neuritis in China
Completed	`NCT03753893` - Ocular Manifestations in Rheumatic Diseases
Completed	`NCT02939937` - Effect of Phenytoin on the Ganglion Cell Layer in Patients With Optic Neuritis	Phase 2